Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 252-258

  Chew, S F ^a,b   Wood, B R ^a   Kanaan, C ^b   Browning, J ^c   MacGregor, D ^c   Davis, I D ^c   Cebon, J ^c   Tait, B D ^b   McNaughton, D ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

FTIR microscopy; HLA class I; Immunohistochemical staining; Melanoma

Indexed keywords

ANTIBODY; HLA ANTIGEN CLASS 1; TISSUE ANTIGEN;

ANTIGEN EXPRESSION; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CLUSTER ANALYSIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; INFRARED SPECTROSCOPY; MELANOMA; METHODOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE SECTION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MELANOMA; SKIN NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 34247260601     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00775.x     Document Type: Conference Paper

References (16)

1. Townsend A, Bodmer H. Antigen recognition by class I restricted T-lymphocytes. Annu Rev Immunol 1989: 7: 601-24.
2. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984: 38: 287-92.
3. Blades RA, Keating PJ, McWilliam LJ, George NJR, Stern PL. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology 1995: 46: 681-7.
4. Cabrera T, Fernandez MA, Sierra A et al. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol 1996: 50: 127-34.
5. Tait BD. HLA class I expression on human cancer cells: implications for effective immunotherapy. Hum Immunol 2000: 61: 158-65.
6. Khong HT, Restifo NP. Natural selection of tumour variants in the generation of "tumour escape" phenotypes. Nat Immunol 2002: 3: 999-1005.
7. van Duinen SG, Ruiter DJ, Broecker EB et al. Level of HLA in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 1988: 48: 1019-25.
8. Lewis EN, Treado PJ, Reeder RC et al. Fourier transform spectroscopic imaging using an infrared focal-plane array detector. Anal Chem 1995: 67: 3377-81.
9. Chiriboga L, Xie P, Vigorita V, Zarou D, Zakim D, Diem M. Infrared spectroscopy of human tissue. I. Differentiation and maturation of epithelial cells in human cervix. Biospectroscopy 1998: 4: 47-53.
10. Chiriboga L, Xie P, Vigorita V, Zarou D, Diem M. Infrared spectroscopy of human tissue. II. A comparative study of spectra of biopsies of cervical squamous epithelium and of exfoliated cervical cells. Biospectroscopy 1998: 4: 55-59.
11. Wood BR, Quinn MA, Tait B et al. FTIR microspectroscopic study of cell types and potential confounding variables in screening for cervical malignancies. Biospectroscopy 1998: 4: 75-91.
12. Lasch P, Haensch W, Naumann D, Diem M. Imaging of colorectal adenocarcinoma using FT-IR microspectroscopy and cluster analysis. Biochim Biophys Acta 2004: 1688: 176-86.
13. Wood BR, Chiriboga L, Yee H, Quinn MA, McNaughton D, Diem M. Fourier transformed infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium. Gynecol Oncol 2004: 93: 59-68.
14. Davis ID, Chen W, Jackson H et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(1) and CD8(1) T cell responses in humans. Proc Natl Acad Sci U S A 2004: 101: 10697-702.
15. Diem M, Chiriboga L, Yee H. Infrared spectroscopy of human cells and tissue: VIII. Strategies for analysis of infrared tissue mapping data and applications to liver tissue. Biopolymers 2000: 57: 282-90.
16. Wood BR, Tait BD, McNaughton D. Fourier-transform infrared spectroscopy as a tool for detecting early lymphocyte activation: A new approach to histocompatibility matching. Hum Immunol 2000: 61: 1307-15.